Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on August 03, 2007
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Opioid-Related Disorders; Substance-Related Disorders
Intervention: Dextromethorphan (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
Charles O'Brien, M.D., Ph.D., Principal Investigator, Affiliation: PDVAMC Treatment Research Center
Summary
The purpose of this study is to determine if addition of dextromethorphan to a stable dose of methadone in opioid dependent subjects will significantly affect physical and psychological aspects of opioid tolerance.
Clinical Details
Official title:
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients
Study design: Interventional, Treatment
Eligibility
Minimum age: 21 Years.
Maximum age: 55 Years.
Gender(s): Both.
Criteria:
Please contact site for information.
Locations and Contacts
University of Pennsylvania, Philadelphia, Pennsylvania 19104 6178, United States
Additional Information
Starting date:
December 1996
Last updated: June 23, 2005
|
